ATE131061T1 - Förderung der osteogenese durch verwendung von vitamin d-derivaten. - Google Patents

Förderung der osteogenese durch verwendung von vitamin d-derivaten.

Info

Publication number
ATE131061T1
ATE131061T1 AT90103916T AT90103916T ATE131061T1 AT E131061 T1 ATE131061 T1 AT E131061T1 AT 90103916 T AT90103916 T AT 90103916T AT 90103916 T AT90103916 T AT 90103916T AT E131061 T1 ATE131061 T1 AT E131061T1
Authority
AT
Austria
Prior art keywords
vitamin
derivatives
promoting osteogenesis
hydrogen atom
hydroxyl group
Prior art date
Application number
AT90103916T
Other languages
English (en)
Inventor
Toshio Matsumoto
Yasuho Nishii
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE131061T1 publication Critical patent/ATE131061T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT90103916T 1989-02-28 1990-02-28 Förderung der osteogenese durch verwendung von vitamin d-derivaten. ATE131061T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4809889 1989-02-28

Publications (1)

Publication Number Publication Date
ATE131061T1 true ATE131061T1 (de) 1995-12-15

Family

ID=12793841

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90103916T ATE131061T1 (de) 1989-02-28 1990-02-28 Förderung der osteogenese durch verwendung von vitamin d-derivaten.

Country Status (6)

Country Link
US (1) US5053401A (de)
EP (1) EP0385446B1 (de)
AT (1) ATE131061T1 (de)
CA (1) CA2010982C (de)
DE (1) DE69023939T2 (de)
HK (1) HK1005015A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9017890D0 (en) 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
US5693615A (en) * 1991-06-05 1997-12-02 The Procter & Gamble Company Therapeutic compositions for osteoinduction
US5486509A (en) * 1991-06-28 1996-01-23 University Of Miami Method of preventing and treating chemotherapy-induced alopecia
KR960013798B1 (ko) * 1992-04-24 1996-10-10 재단법인 한국전자통신연구소 평면 도파로형 공간 스위치
AU666529B2 (en) * 1992-04-24 1996-02-15 Wisconsin Alumni Research Foundation Method of treating osteoporosis with 1 alpha, 24 (R)-dihydroxy-22 (E)-dehydro-vitamin D3
GB9220272D0 (en) * 1992-09-25 1992-11-11 Leo Pharm Prod Ltd Chemical compounds
JPH08505147A (ja) * 1992-12-29 1996-06-04 エフ． ホリック、マイケル 骨粗鬆症の治療又は予防に関するビタミンｄグリコシドの用途
DE59912395D1 (de) * 1998-02-03 2005-09-15 Framatome Anp Gmbh Druckspeicher und verfahren zum bereitstellen eines unter druck stehenden fluids
AUPP794898A0 (en) * 1998-12-24 1999-01-28 Garvan Institute Of Medical Research Transgenic animal

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0184112B1 (de) * 1984-11-27 1990-05-09 Chugai Seiyaku Kabushiki Kaisha Vitamin D-Derivate und Verfahren zu deren Herstellung
JPS61267550A (ja) 1984-12-28 1986-11-27 Chugai Pharmaceut Co Ltd ９，１０−セコ−５，７，１０（１９）−プレグナトリエン誘導体

Also Published As

Publication number Publication date
CA2010982A1 (en) 1990-08-31
EP0385446B1 (de) 1995-12-06
DE69023939T2 (de) 1996-05-09
CA2010982C (en) 2000-06-13
DE69023939D1 (de) 1996-01-18
EP0385446A2 (de) 1990-09-05
US5053401A (en) 1991-10-01
EP0385446A3 (de) 1991-10-30
HK1005015A1 (en) 1998-12-18

Similar Documents

Publication Publication Date Title
FI956270A (fi) Piperdiinijohdannaisia ja menetelmä niiden valmistamiseksi
ES2077138T3 (es) Derivados de aminocumarano, su produccion y su uso.
DE3881246T2 (de) Durch Benzhydryl N-substituierte heterocyclische Derivate, ihre Herstellung und ihre Verwendung.
ATE119774T1 (de) Imidazopyridinderivate und ihre verwendung.
ATE93838T1 (de) Triphenylmethan-derivate.
HUT59394A (en) Process for producing piperazine derivatives and pharmaceutical compositions comprising same
PT81855B (pt) Processo de preparacao de arilciclobutilalquilaminas e de composicoes farmaceuticas que as contem
ATE131061T1 (de) Förderung der osteogenese durch verwendung von vitamin d-derivaten.
DE68917357D1 (de) Derivate der Coffeinsäure und pharmazeutische Zusammensetzungen, die sie enthalten.
ATE114465T1 (de) Pharmazeutische zusammensetzung zur inhibierung der knochenresorption.
DK0414422T3 (da) 2-Oxo-1-oxa-8-azaspiro(4,5)decan-derivater, fremgangsmåder til deres fremstilling samt præparater deraf
PT91607A (pt) Process for the preparation of substituted beta-diketones and of pharmaceutical compositions containing them
ES2169220T3 (es) Derivados de vitamina d3 con sustituyentes en la posicion 2.
FI844185A0 (fi) N-substituerade isokinolinderivat och foerfarande foer framstaellning daerav.
DE69008473D1 (de) Dicyclohexylethylenderivate.
NO842345L (no) Heksahydropyrrolo(2,1-a)isoquinolin-derivater.
NO872982D0 (no) Nye tetracykliske indolderivater.
ES2044883T3 (es) Procedimiento para preparar quinoxalinas sustituidas.
ATE189813T1 (de) Prostaglandin-i-analoga

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee